Commercial benchmarks, trends and practices to drive revenue growth
The buyer journey is changing and ~80% of pharmaceutical organizations are shifting to complex strategic models.
The Alexander Group’s latest research has identified FOUR distinct commercial models being deployed by the therapeutic area and product life cycle. Organizations are investing in new roles across these models to drive growth and improve patient outcomes.
Pharmaceutical leaders across multiple divisions weighed in on the top commercial trends, threats, initiatives and investments to improve sales productivity in Alexander Group’s Pharmaceutical Commercial Study.
What’s in it for you?
Learn how growth-oriented Pharmaceutical and Biotech companies are:
- Focusing on new buyers and changing buyer needs
- Deploying new roles and distinct customer-aligned GTM structures
- Increasing focus on delivering patient-centric support
How does your organization stack up against the leaders in the industry? Where are you under-/over-invested, and what are your key improvement areas as you strive towards growth in 2020?
Sign up for a complimentary briefing today!